Literature DB >> 15572201

The F1-ATPase beta-subunit is the putative enterostatin receptor.

Miejung Park1, Ling Lin, Sonyja Thomas, Hugh D Braymer, Pamela M Smith, David H T Harrison, David A York.   

Abstract

It has been suggested that the F1-ATPase beta-subunit is the enterostatin receptor. We investigated the binding activity of the purified protein with a labeled antagonist, beta-casomorphin1-7, in the absence and presence of cold enterostatin. 125I-beta-casomorphin1-7 weakly binds to the rat F1-ATPase beta-subunit. Binding was promoted by low concentrations of cold enterostatin but displaced by higher concentrations. To study the relationship between binding activity and feeding behavior, we examined the ability of a number of enterostatin analogs to affect beta-casomorphin1-7 binding to the F1-ATPase beta-subunit. Peptides that suppressed food intake promoted beta-casomorphin1-7 binding whereas peptides that stimulated food intake or did not affect the food intake displaced beta-casomorphin1-7 binding. Surface plasmon resonance measurements show that the beta-subunit of F1-ATPase binds immobilized enterostatin with a dissociation constant of 150 nM, where no binding could be detected for the assembled F1-ATPase complex. Western blot analysis showed the F1-ATPase beta-subunit was present on plasma and mitochondrial membranes of rat liver and amygdala. The data provides evidence that the F1-ATPase beta-subunit is the enterostatin receptor and suggests that enterostatin and beta-casomorphin1-7 bind to distinct sites on the protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572201     DOI: 10.1016/j.peptides.2004.08.022

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  15 in total

Review 1.  Ecto-F₁-ATPase: a moonlighting protein complex and an unexpected apoA-I receptor.

Authors:  Pierre Vantourout; Claudia Radojkovic; Laeticia Lichtenstein; Véronique Pons; Eric Champagne; Laurent O Martinez
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

Review 2.  Leucine metabolism in regulation of insulin secretion from pancreatic beta cells.

Authors:  Jichun Yang; Yujing Chi; Brant R Burkhardt; Youfei Guan; Bryan A Wolf
Journal:  Nutr Rev       Date:  2010-05       Impact factor: 7.110

3.  Enterostatin inhibition of dietary fat intake is modulated through the melanocortin system.

Authors:  Ling Lin; Miejung Park; David A York
Journal:  Peptides       Date:  2006-11-17       Impact factor: 3.750

Review 4.  Gastrointestinal regulation of food intake.

Authors:  David E Cummings; Joost Overduin
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 5.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

6.  A primary colonic crypt model enriched in enteroendocrine cells facilitates a peptidomic survey of regulated hormone secretion.

Authors:  Svetlana E Nikoulina; Nancy L Andon; Kevin M McCowen; Michelle D Hendricks; Carolyn Lowe; Steven W Taylor
Journal:  Mol Cell Proteomics       Date:  2010-01-15       Impact factor: 5.911

7.  Enterostatin alters protein trafficking to inhibit insulin secretion in Beta-TC6 cells.

Authors:  Miejung Park; Jeffery Farrell; Karalee Lemmon; David A York
Journal:  Peptides       Date:  2009-06-27       Impact factor: 3.750

8.  Chloroplast membranes retard fat digestion and induce satiety: effect of biological membranes on pancreatic lipase/co-lipase.

Authors:  Per-Ake Albertsson; Rickard Köhnke; Sinan C Emek; Jie Mei; Jens F Rehfeld; Hans-Erik Akerlund; Charlotte Erlanson-Albertsson
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

9.  Different metabolic responses to central and peripheral injection of enterostatin.

Authors:  Ling Lin; Miejung Park; Matt Hulver; David A York
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-12-08       Impact factor: 3.619

Review 10.  Coupling factor 6 as a novel vasoactive and proatherogenic peptide in vascular endothelial cells.

Authors:  Tomohiro Osanai; Koji Magota; Ken Okumura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-06-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.